Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA SUVEN LIFE SCIENCES ALEMBIC PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 32.2 -20.5 - View Chart
P/BV x 4.4 5.8 76.3% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ALEMBIC PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
SUVEN LIFE SCIENCES
Mar-23
ALEMBIC PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs79294 845.0%   
Low Rs46345 1,029.3%   
Sales per share (Unadj.) Rs287.60.6 46,319.5%  
Earnings per share (Unadj.) Rs17.4-5.4 -320.8%  
Cash flow per share (Unadj.) Rs31.4-5.1 -613.1%  
Dividends per share (Unadj.) Rs8.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs222.317.2 1,291.9%  
Shares outstanding (eoy) m196.56218.07 90.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.2111.8 2.0%   
Avg P/E ratio x36.1-12.8 -282.0%  
P/CF ratio (eoy) x20.0-13.5 -147.6%  
Price / Book Value ratio x2.84.0 70.0%  
Dividend payout %46.00-   
Avg Mkt Cap Rs m123,40215,131 815.6%   
No. of employees `000NANA-   
Total wages/salary Rs m11,691186 6,278.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,526135 41,750.6%  
Other income Rs m3084 36.0%   
Total revenues Rs m56,557220 25,721.6%   
Gross profit Rs m6,772-1,196 -566.0%  
Depreciation Rs m2,75465 4,209.5%   
Interest Rs m5025 9,325.3%   
Profit before tax Rs m3,546-1,183 -299.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1260-   
Profit after tax Rs m3,420-1,183 -289.2%  
Gross profit margin %12.0-883.6 -1.4%  
Effective tax rate %3.60-   
Net profit margin %6.1-873.5 -0.7%  
BALANCE SHEET DATA
Current assets Rs m29,1393,455 843.4%   
Current liabilities Rs m16,4081,050 1,562.3%   
Net working cap to sales %22.51,776.0 1.3%  
Current ratio x1.83.3 54.0%  
Inventory Days Days103,948 0.2%  
Debtors Days Days7218 3.1%  
Net fixed assets Rs m31,4981,373 2,293.7%   
Share capital Rs m393218 180.3%   
"Free" reserves Rs m43,3123,535 1,225.2%   
Net worth Rs m43,7053,753 1,164.5%   
Long term debt Rs m00-   
Total assets Rs m60,6374,828 1,255.9%  
Interest coverage x8.1-218.8 -3.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90 3,324.3%   
Return on assets %6.5-24.4 -26.5%  
Return on equity %7.8-31.5 -24.8%  
Return on capital %9.3-31.4 -29.5%  
Exports to sales %46.440.4 114.7%   
Imports to sales %12.1839.8 1.4%   
Exports (fob) Rs m26,21055 47,872.1%   
Imports (cif) Rs m6,8461,137 602.1%   
Fx inflow Rs m26,21055 47,872.1%   
Fx outflow Rs m6,8461,137 602.1%   
Net fx Rs m19,364-1,082 -1,789.2%   
CASH FLOW
From Operations Rs m7,240-1,031 -701.9%  
From Investments Rs m-4,476-2,606 171.7%  
From Financial Activity Rs m-2,6203,955 -66.2%  
Net Cashflow Rs m144317 45.3%  

Share Holding

Indian Promoters % 69.1 69.6 99.3%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 19.0 0.6 3,458.2%  
FIIs % 4.5 0.5 837.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 30.4 99.9%  
Shareholders   85,212 74,003 115.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Suven Life Sciences Share Price Performance

Period ALEMBIC PHARMA Suven Life Sciences S&P BSE HEALTHCARE
1-Day -0.15% 0.30% 1.18%
1-Month -4.30% -2.06% -0.75%
1-Year 105.43% 114.92% 61.82%
3-Year CAGR 0.89% 14.94% 18.16%
5-Year CAGR 13.56% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.